Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral
-
-
-
-
-
-
-
Zymeworks (ZYME) Reiterated at Market Outperform by Citizens on ZW191 Efficacy Data
-
-
-
-
-
-
-
Zymeworks (ZYME) Reiterated at Buy by Stifel After AACR Presentation
-
-
-
-
-
-
-
Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
-
-
-
-
-
-
-
Citizens Starts Zymeworks (ZYME) at Market Outperform
-
-
-
-
-
-
-
Zymeworks (ZYME) PT Raised to $37 at Leerink Partners
-
-
-
-
-
-
-
InMed Pharmaceuticals Appoints Mr. Neil Klompas to It's Board of Directors
-
468,578 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


